StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report report published on Saturday. The brokerage issued a hold rating on the stock.
China Pharma Stock Performance
Shares of NYSE:CPHI opened at $0.18 on Friday. The business has a fifty day simple moving average of $0.24 and a 200-day simple moving average of $0.33. China Pharma has a 52 week low of $0.17 and a 52 week high of $1.77. The company has a quick ratio of 0.25, a current ratio of 0.89 and a debt-to-equity ratio of 0.17.
China Pharma (NYSE:CPHI – Get Free Report) last posted its quarterly earnings data on Wednesday, May 15th. The company reported ($0.07) EPS for the quarter. China Pharma had a negative net margin of 55.42% and a negative return on equity of 54.31%. The company had revenue of $1.37 million for the quarter.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Further Reading
- Five stocks we like better than China Pharma
- What Are Dividend Champions? How to Invest in the Champions
- How to Invest in Silver: A Beginner’s Guide
- What is a buyback in stocks? A comprehensive guide for investors
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- Canadian Penny Stocks: Can They Make You Rich?
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.